[1] |
Tjin Tham Sjin RM,Satchi-Fainaro R,Birsner AE,et al.A 27-amino-acid synthetic peptide corresponding to the NH2 terminal zinc-binding domain of endostatin is responsible for its antitumor activity[J].Cancer Res,2005,65(9):3656-3663.
|
[2] |
Li D,Liu X,Zhao W,et al.Gene cloning,expression and activity of anti-tumor peptide of human endostatin[J].J Med Mol Biol,2007,4(6):475-479.
|
[3] |
Wang SJ,Liu XH,Ji YB,et al.Study on biological activity of two modified anti-tumor peptide of tumstatin[J].Prog Biochem Biophys,2007,34(11):1152-1161.
|
[4] |
Wickstrom SA,Alitalo K,Keski-Oja J.An endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial Cells[J].J Biol Chem,2004,279(9):20 178-20 185.
|
[5] |
Chen BQ,Yang YM,Gao YH,et al.Inhibitory effects of c9,t11-conjugated linoleic acid on invasion of human gastric carcinoma cell line SGC-7901[J].World J Gastroenterol,2003,9(9):1909-1914.
|
[6] |
Poluzzi C,Iozzo RV,Schaefer L.Endostatin and endorepellin:A common route of action for similar angiostatic cancer avengers[J].Adv Drug Deliv Rev,2016,97:156-173.
|
[7] |
O'Reilly MS,Boehm T,Shing Y,et al.Endostatin:An endogenous inhibitor of angiogenesis and tumor growth[J].Cell,1997,88(2):277-285.
|
[8] |
曲波,秦晓风.重组人血管内皮抑素联合卡培他滨及奥沙利铂治疗胃肠癌合并恶性腹腔积液的疗效[J].中国肿瘤临床与康复,2018,25(4):443-445.
|
[9] |
Wan YY,Tian GY,Guo HS,et al.Endostatin,an angiogenesis inhibitor,ameliorates bleomycin-induced pulmonary fibrosis in rats[J].Respir Res,2013,14(1):56-68.
|
[10] |
韩敏,王坚,王久胜.重组人内皮抑素结合化疗对晚期非小细胞肺癌患者血清LMTK-3和IGFBP-7的影响[J].中国现代医学杂志,2018,28(9):55-59.
|
[17] |
王峥嵘,庞静欢,周艳,等.FXR mRNA表达量与肝恶性肿瘤复发转移关系探讨[J].中国现代医生,2017,55(7):1-4.
|
[18] |
李永庆,尚培中,柳勇,等.VEGF和SLeX表达与甲状腺乳头状癌浸润转移的关系[J].中国医学创新,2016,13(21):5-8.
|
[11] |
Thysiadis S,Katsamakas S,Dalezis P,et al.Novel c(RGDyK)-based conjugates of POPAM and 5-fluorouracil for integrin-targeted cancer therapy[J].Future Med Chem,2017,9(18):2181-2196.
|
[12] |
Bartolomé RA,Peláez-García A,Gomez I,et al.An RGD motif present in cadherin 17 induces integrin activation and tumor growth[J].J Biol Chem,2014,289(50):34 801-34 814.
|
[13] |
Boudjadi S,Carrier JC,Groulx JF,et al.Integrin α1β1expression is controlled by c-MYC in colorectal cancer cells[J].Oncogene,2016,35(13):1671-1678.
|
[14] |
Nieberler M,Reuning U,Reichart F,et al.Exploring the role of RGD-recognizing integrins in cancer[J].Cancers,2017,9(9):116-149.
|
[15] |
Xie F,Ding RL,He WF,et al.In vivo antitumor effect ofendostatin-loaded chitosan nanoparticles combined with paclitaxel on Lewis lung carcinoma[J].Drug Deliv,2017,24(1):1410-1418.
|
[16] |
Wang X,Zhan RY,Wang YY,et al.Endostatin improves cancer-associated systemic syndrome in a lung cancer model[J].Oncol Lett,2015,9(5):2023-2030.
|
[19] |
Erreni M,Siddiqui I,Marelli G,et al.The Fractalkine-receptor axis improves human colorectal cancer prognosis by limiting tumor metastatic dissemination[J].J Immunol,2016,196(2):902-914.
|
[20] |
吴迅.重组人血管内皮抑素时间窗研究进展[J].西部医学,2017,29(12):1777-1780.
|
[21] |
Rosca EV,Koskimaki JE,Rivera CG,et al.Anti-angiogenic peptides for cancer therapeutics[J].Curr Pharm Biotechnol,2011,12(8):1101-1116.
|
[22] |
Hamley IW.Small bioactive peptides for biomaterials design and therapeutics[J].Chem Rev,2017,117(24):14 015-14 041.
|